1654 related articles for article (PubMed ID: 29070703)
1. RNA editing with CRISPR-Cas13.
Cox DBT; Gootenberg JS; Abudayyeh OO; Franklin B; Kellner MJ; Joung J; Zhang F
Science; 2017 Nov; 358(6366):1019-1027. PubMed ID: 29070703
[TBL] [Abstract][Full Text] [Related]
2. A cytosine deaminase for programmable single-base RNA editing.
Abudayyeh OO; Gootenberg JS; Franklin B; Koob J; Kellner MJ; Ladha A; Joung J; Kirchgatterer P; Cox DBT; Zhang F
Science; 2019 Jul; 365(6451):382-386. PubMed ID: 31296651
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Engineered CRISPR-Cas-Mediated Systems for Site-Specific RNA Editing.
Marina RJ; Brannan KW; Dong KD; Yee BA; Yeo GW
Cell Rep; 2020 Nov; 33(5):108350. PubMed ID: 33147453
[TBL] [Abstract][Full Text] [Related]
4. Harnessing CRISPR/Cas systems for programmable transcriptional and post-transcriptional regulation.
Mahas A; Neal Stewart C; Mahfouz MM
Biotechnol Adv; 2018; 36(1):295-310. PubMed ID: 29197619
[TBL] [Abstract][Full Text] [Related]
5. Developing PspCas13b-based enhanced RESCUE system, eRESCUE, with efficient RNA base editing.
Li G; Wang Y; Li X; Wang Y; Huang X; Gao J; Hu X
Cell Commun Signal; 2021 Aug; 19(1):84. PubMed ID: 34380502
[TBL] [Abstract][Full Text] [Related]
6. Implementation of the CRISPR-Cas13a system in fission yeast and its repurposing for precise RNA editing.
Jing X; Xie B; Chen L; Zhang N; Jiang Y; Qin H; Wang H; Hao P; Yang S; Li X
Nucleic Acids Res; 2018 Sep; 46(15):e90. PubMed ID: 29860393
[TBL] [Abstract][Full Text] [Related]
7. Transcriptome Engineering with RNA-Targeting Type VI-D CRISPR Effectors.
Konermann S; Lotfy P; Brideau NJ; Oki J; Shokhirev MN; Hsu PD
Cell; 2018 Apr; 173(3):665-676.e14. PubMed ID: 29551272
[TBL] [Abstract][Full Text] [Related]
8. Comprehensive interrogation of the ADAR2 deaminase domain for engineering enhanced RNA editing activity and specificity.
Katrekar D; Xiang Y; Palmer N; Saha A; Meluzzi D; Mali P
Elife; 2022 Jan; 11():. PubMed ID: 35044296
[TBL] [Abstract][Full Text] [Related]
9. Compact RNA editors with small Cas13 proteins.
Kannan S; Altae-Tran H; Jin X; Madigan VJ; Oshiro R; Makarova KS; Koonin EV; Zhang F
Nat Biotechnol; 2022 Feb; 40(2):194-197. PubMed ID: 34462587
[TBL] [Abstract][Full Text] [Related]
10. Targeted activation of diverse CRISPR-Cas systems for mammalian genome editing via proximal CRISPR targeting.
Chen F; Ding X; Feng Y; Seebeck T; Jiang Y; Davis GD
Nat Commun; 2017 Apr; 8():14958. PubMed ID: 28387220
[TBL] [Abstract][Full Text] [Related]
11. A versatile toolkit for CRISPR-Cas13-based RNA manipulation in Drosophila.
Huynh N; Depner N; Larson R; King-Jones K
Genome Biol; 2020 Nov; 21(1):279. PubMed ID: 33203452
[TBL] [Abstract][Full Text] [Related]
12. Non-viral delivery of genome-editing nucleases for gene therapy.
Wang M; Glass ZA; Xu Q
Gene Ther; 2017 Mar; 24(3):144-150. PubMed ID: 27797355
[TBL] [Abstract][Full Text] [Related]
13. Optimization of specific RNA knockdown in mammalian cells with CRISPR-Cas13.
Burris BJD; Molina Vargas AM; Park BJ; O'Connell MR
Methods; 2022 Oct; 206():58-68. PubMed ID: 35987443
[TBL] [Abstract][Full Text] [Related]
14. Programmable System of Cas13-Mediated RNA Modification and Its Biological and Biomedical Applications.
Tang T; Han Y; Wang Y; Huang H; Qian P
Front Cell Dev Biol; 2021; 9():677587. PubMed ID: 34386490
[TBL] [Abstract][Full Text] [Related]
15. Applications of the versatile CRISPR-Cas13 RNA targeting system.
Kordyś M; Sen R; Warkocki Z
Wiley Interdiscip Rev RNA; 2022 May; 13(3):e1694. PubMed ID: 34553495
[TBL] [Abstract][Full Text] [Related]
16. A New Method for Programmable RNA Editing Using CRISPR Effector Cas13X.1.
Li L; Liu W; Zhang H; Cai Q; Wen D; Du J; Sun J; Li L; Gao C; Lin P; Wu M; Jiang J
Tohoku J Exp Med; 2023 May; 260(1):51-61. PubMed ID: 36823185
[TBL] [Abstract][Full Text] [Related]
17. Photoactivatable RNA N
Zhao J; Li B; Ma J; Jin W; Ma X
Small; 2020 Jul; 16(30):e1907301. PubMed ID: 32583968
[TBL] [Abstract][Full Text] [Related]
18. Programmable RNA base editing with photoactivatable CRISPR-Cas13.
Yu J; Shin J; Yu J; Kim J; Yu D; Heo WD
Nat Commun; 2024 Jan; 15(1):673. PubMed ID: 38253589
[TBL] [Abstract][Full Text] [Related]
19. Efficient fdCas9 Synthetic Endonuclease with Improved Specificity for Precise Genome Engineering.
Aouida M; Eid A; Ali Z; Cradick T; Lee C; Deshmukh H; Atef A; AbuSamra D; Gadhoum SZ; Merzaban J; Bao G; Mahfouz M
PLoS One; 2015; 10(7):e0133373. PubMed ID: 26225561
[TBL] [Abstract][Full Text] [Related]
20. Altered editing in RNA editing adenosine deaminase ADAR2 gene transcripts of systemic lupus erythematosus T lymphocytes.
Laxminarayana D; O'Rourke KS; Maas S; Olorenshaw I
Immunology; 2007 Jul; 121(3):359-69. PubMed ID: 17376196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
